{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:52:17Z","timestamp":1759513937389},"reference-count":32,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background.<\/jats:title><jats:p>An increasing number of cases of osteonecrosis of the jaws (ONJ) in patients treated with bisphosphonates has been reported in the literature. ONJ significantly affects the patients' quality of life and its management is still extremely difficult.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A woman with ONJ secondary to therapy with zoledronic acid came to our attention for recurrent oral infections and orocutaneous fistula unresponsive to antibiotic therapy combined with minor surgical debridements. The patient underwent major surgery to remove the fistula and clean the necrotic bone and soft tissues; a lobed skin platysma flap was used to close the defect. The treatment outcome was good.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>When ONJ fails to respond to antibiotic therapy and surgical debridements, a more invasive surgical approach may be necessary to guarantee a better quality of life for the patient. \u00a9 2009 Wiley Periodicals, Inc. Head Neck, 2009<\/jats:p><\/jats:sec>","DOI":"10.1002\/hed.21019","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T01:55:39Z","timestamp":1236131739000},"page":"1249-1254","source":"Crossref","is-referenced-by-count":12,"title":["Bisphosphonate\u2010associated osteonecrosis of the jaws: The limits of a conservative approach"],"prefix":"10.1002","volume":"31","author":[{"given":"Giancarlo","family":"Tirelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Biasotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Chiandussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"De Nardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Di Lenarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.558"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.017"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh141"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.037"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20308"},{"key":"e_1_2_5_7_2","unstructured":"US Food and Drug Administration. Medwatch 2004 safety alert. Zometa (zoledronic acid) injection.2004. Available athttp:\/\/www.fda.gov\/medwatch\/SAFETY\/2004\/safety04.htm#zometa."},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1970.tb00591.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.165.3899.1262"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114100"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","article-title":"Bisphosphonates: mechanism of action","volume":"9","author":"Fleisch H","year":"1998","journal-title":"Endocrine Rev"},{"key":"e_1_2_5_12_2","first-page":"31","volume-title":"Bisphosphonates in bone disease; from the laboratory to the patient","author":"Fleisch H","year":"1995"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650140212"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09699260.1996.11746735","article-title":"New roles for bisphosphonates in cancer therapy","volume":"4","author":"Coleman RE","year":"1996","journal-title":"Prog Palliat Care"},{"key":"e_1_2_5_15_2","first-page":"1055","article-title":"Pamidronate induces modifications of circulating angiogenic factors in cancer patients","volume":"302","author":"Santini D","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","article-title":"Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic lesions: a randomized placebo\u2010controlled trial","volume":"17","author":"Theriualt RL","year":"1999","journal-title":"J Clin Oncol"},{"key":"e_1_2_5_17_2","first-page":"36","volume-title":"Oral and maxillofacial pathology: a rational for diagnosis and treatment","author":"Marx RE","year":"2003"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.22.14_suppl.8088"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.07.010"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21130"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06762.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.08.001"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2005.01130.x"},{"key":"e_1_2_5_24_2","first-page":"100","article-title":"Osteonecrosis of the jaws and bisphosphonates","volume":"353","author":"Woo SB","year":"2005","journal-title":"N Engl J Med"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00009"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06761.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.8670"},{"key":"e_1_2_5_28_2","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos MA","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_5_29_2","first-page":"5057","article-title":"Analysis of frequency and risk factors for developing bisphosphonates associated necrosis of the jaw","volume":"106","author":"Pozzi S","year":"2005","journal-title":"Blood (Am Soc Haematol Annu Meet Abstr)"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.2465"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"e_1_2_5_32_2","first-page":"80","article-title":"Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"64","author":"Kademani D","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.08.001"}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.21019","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.21019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:38:50Z","timestamp":1696880330000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.21019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,3]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1002\/hed.21019"],"URL":"https:\/\/doi.org\/10.1002\/hed.21019","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"value":"1043-3074","type":"print"},{"value":"1097-0347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,3]]}}}